BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 18567522)

  • 21. Neuropsychological and electrophysiological indices of neurocognitive dysfunction in bipolar II disorder.
    Andersson S; Barder HE; Hellvin T; Løvdahl H; Malt UF
    Bipolar Disord; 2008 Dec; 10(8):888-99. PubMed ID: 19594504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Auditory even-related brain potentials in hyperthyroidism.
    Ozata M; Ozkardes A; Odabasi Z; Corakci A; Gundogan MA
    Acta Neurol Belg; 1997 Dec; 97(4):228-32. PubMed ID: 9478259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S; Vardi J; Finkelstein Y; Pollak L
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The P300 component in patients with Alzheimer's disease and their biological children.
    Ally BA; Jones GE; Cole JA; Budson AE
    Biol Psychol; 2006 May; 72(2):180-7. PubMed ID: 16337071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P300 and executive function alterations: possible links in a case of Morgagni-Stewart-Morel syndrome.
    Paulus KS; Magnano I; Aiello I; Sechi GP; Rosati G; Casu AR; Piras MR; Cherchi R; Sotgiu S
    Neurol Sci; 2002 Mar; 22(6):459-62. PubMed ID: 11976978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ERPs changes during neuroleptic treatment in schizophrenia--a vulnerability marker in schizophrenia].
    Asato N; Hirayasu Y; Hiramatsu K; Ohta H
    Seishin Shinkeigaku Zasshi; 1999; 101(3):254-76. PubMed ID: 10375977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of bilateral subthalamic deep brain stimulation on long-latency event-related potentials.
    Kovacs N; Balas I; Kellenyi L; Janszky J; Feldmann A; Llumiguano C; Doczi TP; Ajtay Z; Nagy F
    Parkinsonism Relat Disord; 2008 Aug; 14(6):476-80. PubMed ID: 18313971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [P300 in mild cognitive impairment and in dementia].
    Egerházi A; Glaub T; Balla P; Berecz R; Degrell I
    Psychiatr Hung; 2008; 23(5):349-57. PubMed ID: 19129551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of event-related potential P300 in cerebral infarction.
    Tang XF; Huang YN; Cui LY; Du H; Li BH; Zhang LN
    Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(4):205-9. PubMed ID: 2631118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in p300 following two yoga-based relaxation techniques.
    Sarang SP; Telles S
    Int J Neurosci; 2006 Dec; 116(12):1419-30. PubMed ID: 17145677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P300 and respiratory findings in myotonic muscular dystrophy.
    Oliveri M; Fierro B; Lo Presti R; Brighina F; La Bua V; Caimi G
    Funct Neurol; 1999; 14(3):149-54. PubMed ID: 10568215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cognitive impairment in schizophrenic patients on event-related potentials component P300].
    Ohta H; Hokama H; Fukao K; Hirano K; Ogura C
    Seishin Shinkeigaku Zasshi; 1993; 95(6):439-52. PubMed ID: 8372157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of P300 auditory event related potential in detecting cognitive dysfunction in patients with cirrhosis of the liver.
    Sexena N; Bhatia M; Yoshi YK; Garg PK; Tandon RK
    Neurol India; 2001 Dec; 49(4):350-4. PubMed ID: 11799406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Auditory event-related potential abnormalities in bipolar disorder and schizophrenia.
    O'Donnell BF; Vohs JL; Hetrick WP; Carroll CA; Shekhar A
    Int J Psychophysiol; 2004 Jun; 53(1):45-55. PubMed ID: 15172135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Event-related potential P300 in cerebral infarction].
    Tang XF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):177-80, 190. PubMed ID: 1889332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalization of serum GH.
    Kawamata T; Inui A; Hosoda H; Kangawa K; Hori T
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):140-4. PubMed ID: 17466003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
    Bastemir M; Akin F; Yaylali GF
    Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mental processing in primary headache in children and adolescents].
    Zgorzalewicz M
    Przegl Lek; 2006; 63 Suppl 1():18-23. PubMed ID: 17471818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiac effects of GH].
    Fazio S; Sabatini D; Cittadini A; Santomauro M; Merola B; Biondi B; Colao A; Lombardi G; Saccà L
    Minerva Endocrinol; 1993 Sep; 18(3 Suppl 1):69-75. PubMed ID: 8190051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P300 after minor head injury (a follow-up examination).
    von Bierbrauer A; Weissenborn K
    Acta Neurol Belg; 1998 Mar; 98(1):21-6. PubMed ID: 9606435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.